These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 36318618)

  • 1. Doxorubicin causes ferroptosis and cardiotoxicity by intercalating into mitochondrial DNA and disrupting Alas1-dependent heme synthesis.
    Abe K; Ikeda M; Ide T; Tadokoro T; Miyamoto HD; Furusawa S; Tsutsui Y; Miyake R; Ishimaru K; Watanabe M; Matsushima S; Koumura T; Yamada KI; Imai H; Tsutsui H
    Sci Signal; 2022 Nov; 15(758):eabn8017. PubMed ID: 36318618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity.
    Tadokoro T; Ikeda M; Ide T; Deguchi H; Ikeda S; Okabe K; Ishikita A; Matsushima S; Koumura T; Yamada KI; Imai H; Tsutsui H
    JCI Insight; 2020 May; 5(9):. PubMed ID: 32376803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ferroptosis as a target for protection against cardiomyopathy.
    Fang X; Wang H; Han D; Xie E; Yang X; Wei J; Gu S; Gao F; Zhu N; Yin X; Cheng Q; Zhang P; Dai W; Chen J; Yang F; Yang HT; Linkermann A; Gu W; Min J; Wang F
    Proc Natl Acad Sci U S A; 2019 Feb; 116(7):2672-2680. PubMed ID: 30692261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of p62-NRF2 Axis Protects against Doxorubicin-Induced Ferroptosis in Cardiomyocytes: A Novel Role and Molecular Mechanism of Resveratrol.
    Yu W; Chen C; Xu C; Xie D; Wang Q; Liu W; Zhao H; He F; Chen B; Xi Y; Yan Y; Yu L; Cheng J
    Am J Chin Med; 2022; 50(8):2103-2123. PubMed ID: 36309811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of METTL3 ameliorates doxorubicin-induced cardiotoxicity through suppression of TFRC-mediated ferroptosis.
    Wu L; Du Y; Wang L; Zhang Y; Ren J
    Redox Biol; 2024 Jun; 72():103157. PubMed ID: 38631119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethoxyquin is a Competent Radical-Trapping Antioxidant for Preventing Ferroptosis in Doxorubicin Cardiotoxicity.
    Tadokoro T; Ikeda M; Abe K; Ide T; Miyamoto HD; Furusawa S; Ishimaru K; Watanabe M; Ishikita A; Matsushima S; Koumura T; Yamada KI; Imai H; Tsutsui H
    J Cardiovasc Pharmacol; 2022 Nov; 80(5):690-699. PubMed ID: 35881422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective Role of Dioscin against Doxorubicin-Induced Chronic Cardiotoxicity: Insights from Nrf2-GPX4 Axis-Mediated Cardiac Ferroptosis.
    Liu J; Liu H; Deng L; Wang T; Li L; Chen Y; Qu L; Zou W
    Biomolecules; 2024 Mar; 14(4):. PubMed ID: 38672439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Targets for DOX-Induced Cardiomyopathy: Role of Apoptosis vs. Ferroptosis.
    Kitakata H; Endo J; Ikura H; Moriyama H; Shirakawa K; Katsumata Y; Sano M
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paradoxically, iron overload does not potentiate doxorubicin-induced cardiotoxicity in vitro in cardiomyocytes and in vivo in mice.
    Guenancia C; Li N; Hachet O; Rigal E; Cottin Y; Dutartre P; Rochette L; Vergely C
    Toxicol Appl Pharmacol; 2015 Apr; 284(2):152-62. PubMed ID: 25711856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WGX50 mitigates doxorubicin-induced cardiotoxicity through inhibition of mitochondrial ROS and ferroptosis.
    Tai P; Chen X; Jia G; Chen G; Gong L; Cheng Y; Li Z; Wang H; Chen A; Zhang G; Zhu Y; Xiao M; Wang Z; Liu Y; Shan D; He D; Li M; Zhan T; Khan A; Li X; Zeng X; Li C; Ouyang D; Ai K; Chen X; Liu D; Liu Z; Wei D; Cao K
    J Transl Med; 2023 Nov; 21(1):823. PubMed ID: 37978379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sheng-Mai-Yin inhibits doxorubicin-induced ferroptosis and cardiotoxicity through regulation of Hmox1.
    Meng P; Chen Z; Sun T; Wu L; Wang Y; Guo T; Yang J; Zhu J
    Aging (Albany NY); 2023 Sep; 15(19):10133-10145. PubMed ID: 37770231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FTO ameliorates doxorubicin-induced cardiotoxicity by inhibiting ferroptosis via P53-P21/Nrf2 activation in a HuR-dependent m6A manner.
    Yang Y; Ren J; Zhang J; Shi H; Wang J; Yan Y
    Redox Biol; 2024 Apr; 70():103067. PubMed ID: 38316068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the role of ferroptosis in the doxorubicin-induced chronic cardiotoxicity using a murine model.
    Li X; Liang J; Qu L; Liu S; Qin A; Liu H; Wang T; Li W; Zou W
    Chem Biol Interact; 2022 Aug; 363():110008. PubMed ID: 35667395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrogen sulfide alleviates mitochondrial damage and ferroptosis by regulating OPA3-NFS1 axis in doxorubicin-induced cardiotoxicity.
    Wang Y; Ying X; Wang Y; Zou Z; Yuan A; Xiao Z; Geng N; Qiao Z; Li W; Lu X; Pu J
    Cell Signal; 2023 Jul; 107():110655. PubMed ID: 36924813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asiatic acid ameliorates doxorubicin-induced cardiotoxicity by promoting FPN-mediated iron export and inhibiting ferroptosis.
    Wu L; Wang LT; Du YX; Zhang YM; Ren J
    Acta Pharmacol Sin; 2024 Aug; ():. PubMed ID: 39143234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Imbalance of p53-Park7 Signaling Axis Induces Iron Homeostasis Dysfunction in Doxorubicin-Challenged Cardiomyocytes.
    Pan J; Xiong W; Zhang A; Zhang H; Lin H; Gao L; Ke J; Huang S; Zhang J; Gu J; Chang ACY; Wang C
    Adv Sci (Weinh); 2023 May; 10(15):e2206007. PubMed ID: 36967569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of iron overload on mitochondrial function, mitochondrial dynamics, and ferroptosis in cardiomyocytes.
    Sumneang N; Siri-Angkul N; Kumfu S; Chattipakorn SC; Chattipakorn N
    Arch Biochem Biophys; 2020 Feb; 680():108241. PubMed ID: 31891670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salidroside inhibits doxorubicin-induced cardiomyopathy by modulating a ferroptosis-dependent pathway.
    Chen H; Zhu J; Le Y; Pan J; Liu Y; Liu Z; Wang C; Dou X; Lu D
    Phytomedicine; 2022 May; 99():153964. PubMed ID: 35180677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ferritin heavy chain as main mediator of preventive effect of metformin against mitochondrial damage induced by doxorubicin in cardiomyocytes.
    Asensio-Lopez MC; Sanchez-Mas J; Pascual-Figal DA; de Torre C; Valdes M; Lax A
    Free Radic Biol Med; 2014 Feb; 67():19-29. PubMed ID: 24231192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LCZ696 protects against doxorubicin-induced cardiotoxicity by inhibiting ferroptosis via AKT/SIRT3/SOD2 signaling pathway activation.
    Liu X; Li D; Pi W; Wang B; Xu S; Yu L; Yao L; Sun Z; Jiang J; Mi Y
    Int Immunopharmacol; 2022 Dec; 113(Pt A):109379. PubMed ID: 36330913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.